XBiotech amends director bio: Rademaker is consultant to multiple PE firms

XBiotech Inc.

Clarifies Craig Rademaker is a consultant to several Canadian private equity firms, not a single firm.
His responsibilities principally include capital markets activities.
No change to his role as director or any compensatory arrangements.
Amendment corrects prior 8-K filed June 24, 2025, for Item 5.02.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.